Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

Trillium Therapeutics Inc

Website:
trilliumtherapeutics.com
Headquarters:
Toronto, ON, CA
Company Type:
Small Business (1-10M TTM Revenue)

Trillium Therapeutics Inc. (TTI) is a privately-owned biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation. The Company’s cytoprotection programs are based upon a recombinant form of heparin-binding epidermal growth factor-like growth factor (HB-EGF).

Site Badges
Trillium Therapeutics Inc
96 Skyway Avenue Toronto, ON, M9W 4Y9 Canada

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service